| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.929 | 0.003 | 0.929 | Aldehyde oxidase inhibitor | 0.321 0.061 CID_154699670 | ||
| 0.885 | 0.004 | 0.885 | Caspase 9 stimulant | 0.879 0.004 CID_154699670 | ||
| 0.871 | 0.001 | 0.871 | Cystathionine beta-synthase inhibitor | 0.827 0.002 CID_154699670 | ||
| 0.825 | 0.001 | 0.825 | GABA C receptor rho-3 antagonist | 0.46 0.038 CID_154699670 | ||
| 0.821 | 0.004 | 0.835 | Free radical scavenger | 0.835 0.004 CID_154699670 | CID_154699670 | |
| 0.818 | 0.004 | 0.878 | Antioxidant | 0.878 0.004 CID_154699670 | CID_154699670 | |
| 0.809 | 0.003 | 0.895 | Histamine release inhibitor | 0.895 0.002 CID_154699670 | CID_154699670 | |
| 0.817 | 0.015 | 0.824 | Apoptosis agonist | 0.824 0.014 CID_154699670 | CID_154699670 | |
| 0.785 | 0.006 | 0.785 | Aryl hydrocarbon receptor agonist | 0.319 0.056 CID_154699670 | ||
| 0.761 | 0.005 | 0.761 | Amyloid beta aggregation inhibitor | 0.51 0.013 CID_154699670 | ||
| 0.759 | 0.002 | 0.759 | Peroxidase inhibitor | 0.25 0.047 CID_154699670 | ||
| 0.75 | 0.001 | 0.75 | Creatine kinase inhibitor | 0.293 0.004 CID_154699670 | ||
| 0.731 | 0.005 | 0.731 | Caspase 3 stimulant | 0.593 0.011 CID_154699670 | ||
| 0.729 | 0.006 | 0.729 | 12-Lipoxygenase inhibitor | |||
| 0.731 | 0.01 | 0.731 | 15-Lipoxygenase inhibitor | |||
| 0.682 | 0.005 | 0.743 | 5 Hydroxytryptamine release inhibitor | 0.743 0.004 CID_154699670 | CID_154699670 | |
| 0.672 | 0.003 | 0.672 | Interleukin 4 antagonist | 0.421 0.005 CID_154699670 | ||
| 0.663 | 0.002 | 0.663 | GABA C receptor rho-2 antagonist | 0.202 0.028 CID_154699670 | ||
| 0.661 | 0.004 | 0.661 | Breast cancer-resistant protein inhibitor | 0.121 0.039 CID_154699670 | ||
| 0.646 | 0.005 | 0.646 | Superoxide dismutase inhibitor | |||
| 0.66 | 0.039 | 0.854 | Antiinflammatory | 0.854 0.009 CID_154699670 | CID_154699670 | |
| 0.655 | 0.042 | 0.87 | Alpha-glucosidase inhibitor | 0.87 0.01 CID_154699670 | CID_154699670 | |
| 0.637 | 0.027 | 0.879 | Transcription factor NF kappa B inhibitor | 0.879 0.008 CID_154699670 | CID_154699670 | |
| 0.606 | 0.004 | 0.818 | Amylase inhibitor | 0.818 0.002 CID_154699670 | CID_154699670 | |
| 0.585 | 0.005 | 0.85 | Monophenol monooxygenase inhibitor | 0.85 0.003 CID_154699670 | CID_154699670 | |
| 0.584 | 0.005 | 0.584 | MAO inhibitor | |||
| 0.583 | 0.004 | 0.583 | NADPH oxidase inhibitor | 0.5 0.004 CID_154699670 | ||
| 0.589 | 0.01 | 0.589 | Lipoxygenase inhibitor | |||
| 0.58 | 0.004 | 0.58 | MAO A inhibitor | |||
| 0.58 | 0.005 | 0.58 | P-glycoprotein inhibitor | 0.413 0.015 CID_154699670 | ||
| 0.564 | 0.004 | 0.564 | Aldehyde dehydrogenase inhibitor | 0.503 0.004 CID_154699670 | ||
| 0.559 | 0.004 | 0.571 | NOS3 expression enhancer | 0.571 0.004 CID_154699670 | CID_154699670 | |
| 0.557 | 0.005 | 0.776 | Melanin inhibitor | 0.776 0.002 CID_154699670 | CID_154699670 | |
| 0.55 | 0.003 | 0.774 | Xanthine oxidase inhibitor | 0.774 0.002 CID_154699670 | CID_154699670 | |
| 0.536 | 0.012 | 0.598 | Hypoxia-inducible factor 1 alpha inhibitor | 0.598 0.008 CID_154699670 | CID_154699670 | |
| 0.537 | 0.016 | 0.537 | Calcium channel L-type activator | 0.305 0.153 CID_154699670 | ||
| 0.525 | 0.006 | 0.525 | Topoisomerase II inhibitor | 0.524 0.006 CID_154699670 | ||
| 0.53 | 0.013 | 0.772 | Hypoglycemic | 0.772 0.004 CID_154699670 | CID_154699670 | |
| 0.53 | 0.017 | 0.626 | Apoptosis antagonist | 0.626 0.007 CID_154699670 | CID_154699670 | |
| 0.518 | 0.01 | 0.518 | RNA-directed DNA polymerase inhibitor | 0.476 0.012 CID_154699670 | ||
| 0.504 | 0.004 | 0.504 | Estrogen receptor beta antagonist | 0.107 0.052 CID_154699670 | ||
| 0.509 | 0.008 | 0.509 | Pyruvate kinase inhibitor | 0.201 0.08 CID_154699670 | ||
| 0.518 | 0.021 | 0.636 | Spasmolytic | 0.636 0.01 CID_154699670 | CID_154699670 | |
| 0.497 | 0.002 | 0.497 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.152 0.018 CID_154699670 | ||
| 0.497 | 0.004 | 0.497 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.431 0.006 CID_154699670 | ||
| 0.508 | 0.015 | 0.646 | Nitric oxide antagonist | 0.646 0.008 CID_154699670 | CID_154699670 | |
| 0.489 | 0.003 | 0.489 | Carbonic anhydrase III inhibitor | 0.306 0.005 CID_154699670 | ||
| 0.495 | 0.016 | 0.608 | Antiamyloidogenic | 0.608 0.008 CID_154699670 | CID_154699670 | |
| 0.476 | 0.005 | 0.476 | Acetylcholinesterase inhibitor | 0.15 0.055 CID_154699670 | ||
| 0.478 | 0.007 | 0.478 | Dual specificity phosphatase inhibitor | 0.148 0.097 CID_154699670 | ||
| 0.471 | 0.004 | 0.471 | Estrogen antagonist | 0.142 0.027 CID_154699670 | ||
| 0.483 | 0.018 | 0.706 | Vasodilator, coronary | 0.706 0.004 CID_154699670 | CID_154699670 | |
| 0.468 | 0.003 | 0.468 | GABA C receptor antagonist | 0.107 0.068 CID_154699670 | ||
| 0.462 | 0.005 | 0.462 | Chelator | 0.189 0.026 CID_154699670 | ||
| 0.462 | 0.005 | 0.462 | MAO B inhibitor | |||
| 0.462 | 0.007 | 0.5 | Lipid peroxidase inhibitor | 0.5 0.005 CID_154699670 | CID_154699670 | |
| 0.456 | 0.004 | 0.828 | Beta glucuronidase inhibitor | 0.828 0.002 CID_154699670 | CID_154699670 | |
| 0.482 | 0.03 | 0.482 | 5 Hydroxytryptamine release stimulant | 0.306 0.068 CID_154699670 | ||
| 0.468 | 0.017 | 0.506 | DNA damaging | 0.506 0.013 CID_154699670 | CID_154699670 | |
| 0.444 | 0.004 | 0.444 | Topoisomerase II alpha inhibitor | 0.408 0.005 CID_154699670 | ||
| 0.44 | 0.002 | 0.44 | GABA C receptor rho-1 antagonist | 0.132 0.031 CID_154699670 | ||
| 0.442 | 0.008 | 0.442 | 5 Hydroxytryptamine uptake stimulant | 0.201 0.15 CID_154699670 | ||
| 0.479 | 0.046 | 0.479 | Prostaglandin dehydrogenase inhibitor | |||
| 0.442 | 0.01 | 0.661 | Hepatoprotectant | 0.661 0.004 CID_154699670 | CID_154699670 | |
| 0.44 | 0.01 | 0.44 | Dual specificity phosphatase 3 inhibitor | 0.132 0.114 CID_154699670 | ||
| 0.477 | 0.047 | 0.723 | Antibacterial | 0.723 0.007 CID_154699670 | CID_154699670 | |
| 0.439 | 0.018 | 0.509 | Vasodilator | 0.509 0.011 CID_154699670 | CID_154699670 | |
| 0.416 | 0.004 | 0.416 | Histidine decarboxylase inhibitor | 0.077 0.044 CID_154699670 | ||
| 0.414 | 0.004 | 0.414 | Carbonic anhydrase VI inhibitor | 0.228 0.01 CID_154699670 | ||
| 0.41 | 0.003 | 0.412 | Nitric-oxide synthase stimulant | 0.412 0.003 CID_154699670 | CID_154699670 | |
| 0.397 | 0.005 | 0.397 | 5-Lipoxygenase inhibitor | |||
| 0.422 | 0.033 | 0.422 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.394 | 0.01 | 0.394 | Cholinergic | |||
| 0.387 | 0.004 | 0.387 | Estrogen receptor alpha antagonist | |||
| 0.384 | 0.004 | 0.384 | Aldose reductase inhibitor | 0.292 0.005 CID_154699670 | ||
| 0.383 | 0.004 | 0.383 | Carbonic anhydrase XV inhibitor | 0.089 0.084 CID_154699670 | ||
| 0.384 | 0.009 | 0.384 | Protein-tyrosine phosphatase inhibitor | 0.297 0.019 CID_154699670 | ||
| 0.357 | 0.007 | 0.357 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.377 | 0.031 | 0.56 | Tumour necrosis factor alpha release inhibitor | 0.56 0.009 CID_154699670 | CID_154699670 | |
| 0.393 | 0.049 | 0.393 | Streptokinase A inhibitor | |||
| 0.357 | 0.014 | 0.357 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.365 | 0.022 | 0.513 | Cyclic AMP phosphodiesterase inhibitor | 0.513 0.006 CID_154699670 | CID_154699670 | |
| 0.341 | 0.003 | 0.341 | Multidrug resistance-associated protein 1 inhibitor | 0.274 0.004 CID_154699670 | ||
| 0.341 | 0.005 | 0.341 | Estrogen agonist | 0.157 0.011 CID_154699670 | ||
| 0.344 | 0.012 | 0.508 | Protein kinase stimulant | 0.508 0.004 CID_154699670 | CID_154699670 | |
| 0.364 | 0.032 | 0.364 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.361 | 0.03 | 0.361 | Transcription factor STAT inhibitor | |||
| 0.338 | 0.011 | 0.361 | Neurotrophic factor enhancer | 0.361 0.008 CID_154699670 | CID_154699670 | |
| 0.331 | 0.005 | 0.331 | Uric acid excretion stimulant | 0.297 0.005 CID_154699670 | ||
| 0.362 | 0.037 | 0.362 | Interleukin antagonist | 0.168 0.105 CID_154699670 | ||
| 0.326 | 0.005 | 0.345 | Carbonic anhydrase XIII inhibitor | 0.345 0.005 CID_154699670 | CID_154699670 | |
| 0.323 | 0.003 | 0.338 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.338 0.003 CID_154699670 | CID_154699670 | |
| 0.35 | 0.033 | 0.829 | Angiogenesis stimulant | 0.829 0.003 CID_154699670 | CID_154699670 | |
| 0.33 | 0.013 | 0.33 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.324 | 0.009 | 0.352 | Alkaline phosphatase inhibitor | 0.352 0.007 CID_154699670 | CID_154699670 | |
| 0.316 | 0.004 | 0.316 | Cyclin B3 inhibitor | |||
| 0.401 | 0.09 | 0.832 | Cyclophilin D inhibitor | 0.832 0.005 CID_154699670 | CID_154699670 | |
| 0.327 | 0.016 | 0.327 | Tubulin antagonist | |||
| 0.329 | 0.025 | 0.502 | Platelet adhesion inhibitor | 0.502 0.005 CID_154699670 | CID_154699670 | |
| 0.313 | 0.01 | 0.313 | Protein-tyrosine phosphatase 1B inhibitor | 0.262 0.015 CID_154699670 | ||
| 0.335 | 0.04 | 0.335 | Insulysin inhibitor | |||
| 0.295 | 0.003 | 0.295 | Xanthine dehydrogenase inhibitor | 0.165 0.006 CID_154699670 | ||
| 0.304 | 0.014 | 0.304 | Heat shock protein 90 alpha antagonist | |||
| 0.291 | 0.003 | 0.291 | DOPA decarboxylase inhibitor | 0.124 0.041 CID_154699670 | ||
| 0.292 | 0.004 | 0.292 | Histone deacetylase SIRT1 stimulant | 0.249 0.005 CID_154699670 | ||
| 0.292 | 0.004 | 0.292 | Histone deacetylase stimulant | 0.249 0.005 CID_154699670 | ||
| 0.289 | 0.005 | 0.289 | Alcohol dehydrogenase inhibitor | 0.249 0.008 CID_154699670 | ||
| 0.294 | 0.011 | 0.294 | Butyrylcholinesterase inhibitor | |||
| 0.293 | 0.011 | 0.293 | Heat shock protein 90 antagonist | 0.125 0.105 CID_154699670 | ||
| 0.325 | 0.044 | 0.325 | Dyrk kinase inhibitor | |||
| 0.284 | 0.004 | 0.284 | CF transmembrane conductance regulator agonist | 0.219 0.013 CID_154699670 | ||
| 0.277 | 0.003 | 0.277 | GABA B receptor antagonist | |||
| 0.3 | 0.028 | 0.571 | Non-steroidal antiinflammatory agent | 0.571 0.005 CID_154699670 | CID_154699670 | |
| 0.296 | 0.024 | 0.296 | Mcl-1 antagonist | |||
| 0.281 | 0.013 | 0.354 | Topoisomerase I inhibitor | 0.354 0.007 CID_154699670 | CID_154699670 | |
| 0.281 | 0.013 | 0.281 | Protein kinase (CK2) alpha inhibitor | |||
| 0.27 | 0.003 | 0.27 | Fatty acid synthase inhibitor | 0.152 0.005 CID_154699670 | ||
| 0.285 | 0.021 | 0.285 | Amyloid beta precursor protein antagonist | |||
| 0.27 | 0.008 | 0.27 | Telomerase inhibitor | 0.076 0.047 CID_154699670 | ||
| 0.29 | 0.03 | 0.4 | DNA methyltransferase I inhibitor | 0.4 0.009 CID_154699670 | CID_154699670 | |
| 0.279 | 0.021 | 0.279 | Cyclooxygenase inhibitor | 0.182 0.049 CID_154699670 | ||
| 0.273 | 0.018 | 0.273 | Cyclooxygenase 1 inhibitor | 0.176 0.045 CID_154699670 | ||
| 0.256 | 0.004 | 0.256 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.259 | 0.009 | 0.641 | Mediator release inhibitor | 0.641 0.003 CID_154699670 | CID_154699670 | |
| 0.266 | 0.018 | 0.266 | Succinate dehydrogenase inhibitor | 0.144 0.123 CID_154699670 | ||
| 0.254 | 0.006 | 0.254 | Aromatase inhibitor | |||
| 0.242 | 0.003 | 0.242 | D-Ala-D-Ala ligase inhibitor | 0.082 0.063 CID_154699670 | ||
| 0.262 | 0.027 | 0.262 | Tumour necrosis factor antagonist | |||
| 0.277 | 0.043 | 0.277 | MAP kinase kinase 2 inhibitor | |||
| 0.237 | 0.005 | 0.237 | Macrophage migration inhibitory factor inhibitor | |||
| 0.235 | 0.007 | 0.235 | HIV-1 integrase (3'-Processing) inhibitor | 0.124 0.018 CID_154699670 | ||
| 0.231 | 0.004 | 0.231 | Estrogen receptor beta agonist | 0.1 0.011 CID_154699670 | ||
| 0.233 | 0.007 | 0.233 | HIV-1 integrase (Strand Transfer) inhibitor | 0.117 0.017 CID_154699670 | ||
| 0.309 | 0.083 | 0.309 | Calcium channel activator | |||
| 0.231 | 0.008 | 0.341 | Photosensitizer | 0.341 0.004 CID_154699670 | CID_154699670 | |
| 0.248 | 0.025 | 0.248 | Bone formation stimulant | 0.168 0.047 CID_154699670 | ||
| 0.227 | 0.004 | 0.227 | Myeloperoxidase inhibitor | |||
| 0.273 | 0.051 | 0.273 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.261 | 0.043 | 0.389 | DNA methylase inhibitor | 0.389 0.012 CID_154699670 | CID_154699670 | |
| 0.224 | 0.007 | 0.224 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.097 CID_154699670 | ||
| 0.264 | 0.051 | 0.264 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.236 | 0.023 | 0.236 | Cyclooxygenase 2 inhibitor | 0.152 0.052 CID_154699670 | ||
| 0.232 | 0.019 | 0.452 | Alkylator | 0.452 0.006 CID_154699670 | CID_154699670 | |
| 0.248 | 0.036 | 0.248 | Insulin sensitizer | 0.24 0.04 CID_154699670 | ||
| 0.215 | 0.005 | 0.215 | CDC25A inhibitor | 0.098 0.029 CID_154699670 | ||
| 0.215 | 0.005 | 0.233 | Heat shock protein 70 antagonist | 0.233 0.004 CID_154699670 | CID_154699670 | |
| 0.223 | 0.015 | 0.223 | Protein kinase (CK2) inhibitor | |||
| 0.262 | 0.054 | 0.266 | Psychostimulant | 0.266 0.053 CID_154699670 | CID_154699670 | |
| 0.236 | 0.031 | 0.409 | Interferon gamma antagonist | 0.409 0.01 CID_154699670 | CID_154699670 | |
| 0.207 | 0.006 | 0.207 | Alpha tubulin antagonist | |||
| 0.224 | 0.024 | 0.399 | Hexokinase inhibitor | 0.399 0.004 CID_154699670 | CID_154699670 | |
| 0.282 | 0.084 | 0.56 | Immunostimulant | 0.56 0.021 CID_154699670 | CID_154699670 | |
| 0.225 | 0.028 | 0.355 | Alpha-N-acetylglucosaminidase inhibitor | 0.355 0.011 CID_154699670 | CID_154699670 | |
| 0.206 | 0.008 | 0.206 | Keratolytic | |||
| 0.204 | 0.007 | 0.204 | Transcription factor STAT6 inhibitor | |||
| 0.339 | 0.143 | 0.339 | DNA directed DNA polymerase inhibitor | |||
| 0.199 | 0.005 | 0.199 | Carbonic anhydrase VII inhibitor | 0.088 0.011 CID_154699670 | ||
| 0.289 | 0.095 | 0.708 | Antithrombotic | 0.708 0.008 CID_154699670 | CID_154699670 | |
| 0.201 | 0.009 | 0.467 | DNA repair enzyme inhibitor | 0.467 0.003 CID_154699670 | CID_154699670 | |
| 0.196 | 0.005 | 0.196 | Estrogen receptor alpha agonist | |||
| 0.336 | 0.146 | 0.336 | DNA polymerase beta inhibitor | |||
| 0.254 | 0.064 | 0.411 | DNA synthesis inhibitor | 0.411 0.02 CID_154699670 | CID_154699670 | |
| 0.207 | 0.016 | 0.553 | Cyclooxygenase 3 inhibitor | 0.553 0.003 CID_154699670 | CID_154699670 | |
| 0.201 | 0.011 | 0.201 | Protein kinase C zeta inhibitor | |||
| 0.197 | 0.009 | 0.199 | Thioredoxin inhibitor | 0.199 0.008 CID_154699670 | CID_154699670 | |
| 0.208 | 0.02 | 0.208 | Antibacterial (Helicobacter pylori) | 0.126 0.073 CID_154699670 | ||
| 0.216 | 0.029 | 0.399 | Insulin secretagoues | 0.399 0.006 CID_154699670 | CID_154699670 | |
| 0.21 | 0.026 | 0.226 | Mannose-6-phosphate isomerase inhibitor | 0.226 0.019 CID_154699670 | CID_154699670 | |
| 0.212 | 0.029 | 0.212 | Neurotensin receptor agonist | |||
| 0.197 | 0.014 | 0.197 | Androgen antagonist | |||
| 0.187 | 0.012 | 0.187 | Urease inhibitor | |||
| 0.205 | 0.03 | 0.55 | Hemostatic | 0.55 0.004 CID_154699670 | CID_154699670 | |
| 0.187 | 0.013 | 0.556 | AMP-activated protein kinase stimulant | 0.556 0.003 CID_154699670 | CID_154699670 | |
| 0.206 | 0.033 | 0.346 | ATPase inhibitor | 0.346 0.004 CID_154699670 | CID_154699670 | |
| 0.182 | 0.009 | 0.182 | Carbonic anhydrase V inhibitor | |||
| 0.178 | 0.008 | 0.178 | Alcohol oxidase inhibitor | |||
| 0.195 | 0.028 | 0.195 | Cholesterol synthesis inhibitor | 0.145 0.047 CID_154699670 | ||
| 0.174 | 0.007 | 0.174 | Carbonic anhydrase VB inhibitor | |||
| 0.18 | 0.013 | 0.18 | Prolactin inhibitor | |||
| 0.246 | 0.084 | 0.246 | Gastrin inhibitor | 0.19 0.165 CID_154699670 | ||
| 0.19 | 0.028 | 0.19 | Toll-Like receptor 2 antagonist | |||
| 0.247 | 0.086 | 0.247 | Transcription factor STAT3 inhibitor | |||
| 0.173 | 0.012 | 0.173 | Electron transport complex I inhibitor | 0.105 0.071 CID_154699670 | ||
| 0.169 | 0.01 | 0.169 | Glutamate decarboxylase inhibitor | |||
| 0.195 | 0.038 | 0.195 | Arachidonic acid antagonist | |||
| 0.164 | 0.008 | 0.164 | Carbonic anhydrase VA inhibitor | |||
| 0.177 | 0.022 | 0.376 | UDP-glucose 4-epimerase inhibitor | 0.376 0.007 CID_154699670 | CID_154699670 | |
| 0.159 | 0.005 | 0.159 | CD45 antagonist | |||
| 0.188 | 0.035 | 0.391 | Cell wall synthesis inhibitor | 0.391 0.006 CID_154699670 | CID_154699670 | |
| 0.182 | 0.028 | 0.182 | Farnesoid X receptor antagonist | |||
| 0.159 | 0.007 | 0.189 | Neuraminidase (influenza) inhibitor | 0.189 0.005 CID_154699670 | CID_154699670 | |
| 0.171 | 0.019 | 0.171 | TRPA1 agonist | 0.108 0.074 CID_154699670 | ||
| 0.16 | 0.008 | 0.16 | Thioredoxin reductase inhibitor | 0.091 0.04 CID_154699670 | ||
| 0.155 | 0.005 | 0.155 | Aryl hydrocarbon receptor antagonist | |||
| 0.196 | 0.047 | 0.196 | Phospholipase C inhibitor | 0.173 0.069 CID_154699670 | ||
| 0.167 | 0.018 | 0.167 | Sphingomyelinase inhibitor | 0.14 0.029 CID_154699670 | ||
| 0.158 | 0.009 | 0.158 | Interleukin 5 antagonist | 0.131 0.018 CID_154699670 | ||
| 0.21 | 0.063 | 0.21 | I kappa B kinase epsilon inhibitor | |||
| 0.176 | 0.029 | 0.176 | Adenylate cyclase stimulant | 0.124 0.116 CID_154699670 | ||
| 0.168 | 0.022 | 0.168 | Potassium channel (Ca-activated) activator | |||
| 0.151 | 0.005 | 0.151 | Topoisomerase II beta inhibitor | 0.12 0.007 CID_154699670 | ||
| 0.155 | 0.01 | 0.155 | Ornithine decarboxylase inhibitor | 0.128 0.02 CID_154699670 | ||
| 0.155 | 0.011 | 0.155 | Beta tubulin antagonist | |||
| 0.158 | 0.014 | 0.158 | CYP2A6 inhibitor | |||
| 0.169 | 0.027 | 0.325 | Antineoplastic antibiotic | 0.325 0.008 CID_154699670 | CID_154699670 | |
| 0.163 | 0.021 | 0.163 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.189 | 0.048 | 0.287 | Interleukin 6 antagonist | 0.287 0.017 CID_154699670 | CID_154699670 | |
| 0.161 | 0.022 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_154699670 | ||
| 0.175 | 0.037 | 0.191 | DNA polymerase I inhibitor | 0.191 0.031 CID_154699670 | CID_154699670 | |
| 0.166 | 0.029 | 0.166 | GABA C receptor agonist | |||
| 0.137 | 0.003 | 0.137 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.138 | 0.005 | 0.138 | DNA-dependent protein kinase inhibitor | |||
| 0.141 | 0.011 | 0.141 | Lipase inhibitor | 0.099 0.028 CID_154699670 | ||
| 0.181 | 0.053 | 0.181 | Phospholipase A2 inhibitor | 0.148 0.076 CID_154699670 | ||
| 0.131 | 0.003 | 0.131 | ATP citrate lysase inhibitor | 0.037 0.015 CID_154699670 | ||
| 0.251 | 0.124 | 0.515 | Cholesterol antagonist | 0.515 0.03 CID_154699670 | CID_154699670 | |
| 0.134 | 0.008 | 0.154 | Neuraminidase inhibitor | 0.154 0.005 CID_154699670 | CID_154699670 | |
| 0.132 | 0.005 | 0.132 | Cyclin B2 inhibitor | |||
| 0.132 | 0.006 | 0.132 | Cyclin B1 inhibitor | |||
| 0.141 | 0.015 | 0.151 | Interleukin 12 antagonist | 0.151 0.012 CID_154699670 | CID_154699670 | |
| 0.136 | 0.011 | 0.136 | HIV-1 integrase inhibitor | 0.072 0.045 CID_154699670 | ||
| 0.145 | 0.02 | 0.145 | Anabolic | |||
| 0.144 | 0.021 | 0.144 | Aminoacyl-tRNA synthetase inhibitor | 0.103 0.042 CID_154699670 | ||
| 0.25 | 0.128 | 0.25 | Sodium/bile acid cotransporter inhibitor | 0.197 0.192 CID_154699670 | ||
| 0.13 | 0.008 | 0.13 | Maillard reaction inhibitor | 0.091 0.02 CID_154699670 | ||
| 0.13 | 0.009 | 0.13 | CDC25B inhibitor | |||
| 0.14 | 0.023 | 0.14 | Porphobilinogen synthase inhibitor | |||
| 0.12 | 0.005 | 0.12 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.119 | 0.004 | 0.119 | Transcription factor RelA inhibitor | |||
| 0.148 | 0.034 | 0.157 | Mucolytic | 0.157 0.029 CID_154699670 | CID_154699670 | |
| 0.119 | 0.008 | 0.119 | Cyclin B inhibitor | |||
| 0.119 | 0.009 | 0.119 | Protease activated receptor antagonist | |||
| 0.238 | 0.131 | 0.238 | Thyroid hormone antagonist | |||
| 0.19 | 0.085 | 0.19 | Histone acetyltransferase inhibitor | |||
| 0.163 | 0.058 | 0.163 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.107 | 0.004 | 0.107 | Dopamine D5 agonist | |||
| 0.149 | 0.047 | 0.149 | Proteasome inhibitor | |||
| 0.169 | 0.068 | 0.169 | Catenin beta inhibitor | |||
| 0.107 | 0.008 | 0.107 | Glutamate (mGluR7) antagonist | |||
| 0.172 | 0.072 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.126 | 0.029 | 0.235 | Triose-phosphate isomerase inhibitor | 0.235 0.008 CID_154699670 | CID_154699670 | |
| 0.121 | 0.028 | 0.224 | NADH dehydrogenase inhibitor | 0.224 0.009 CID_154699670 | CID_154699670 | |
| 0.245 | 0.152 | 0.525 | Immunosuppressant | 0.525 0.027 CID_154699670 | CID_154699670 | |
| 0.233 | 0.141 | 0.233 | Vasodilator, peripheral | 0.208 0.166 CID_154699670 | ||
| 0.134 | 0.042 | 0.399 | Expectorant | 0.399 0.005 CID_154699670 | CID_154699670 | |
| 0.11 | 0.018 | 0.11 | Leukotriene antagonist | 0.105 0.02 CID_154699670 | ||
| 0.094 | 0.003 | 0.094 | Estrogen-related receptor beta antagonist | |||
| 0.093 | 0.004 | 0.093 | Protein kinase (CK2) beta inhibitor | |||
| 0.115 | 0.026 | 0.115 | Glutathione S-transferase inhibitor | |||
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | |||
| 0.223 | 0.136 | 0.223 | Thyroid hormone beta antagonist | |||
| 0.097 | 0.012 | 0.15 | Carbonic anhydrase XIV inhibitor | 0.15 0.005 CID_154699670 | CID_154699670 | |
| 0.106 | 0.023 | 0.106 | Leukotriene synthesis inhibitor | |||
| 0.092 | 0.01 | 0.092 | Cyclin D1 inhibitor | |||
| 0.111 | 0.029 | 0.111 | Cathepsin G inhibitor | |||
| 0.178 | 0.097 | 0.178 | Antimitotic | |||
| 0.103 | 0.023 | 0.103 | Potassium channel large-conductance Ca-activated activator | |||
| 0.102 | 0.022 | 0.102 | Estrogen-related receptor beta agonist | |||
| 0.143 | 0.063 | 0.143 | Interleukin 1 antagonist | |||
| 0.129 | 0.051 | 0.129 | Interleukin 8 antagonist | |||
| 0.13 | 0.052 | 0.201 | DNA intercalator | 0.201 0.025 CID_154699670 | CID_154699670 | |
| 0.095 | 0.018 | 0.095 | MAP kinase kinase 7 inhibitor | |||
| 0.081 | 0.005 | 0.135 | Arginase inhibitor | 0.135 0.003 CID_154699670 | CID_154699670 | |
| 0.082 | 0.006 | 0.082 | Cholesterol esterase inhibitor | 0.044 0.04 CID_154699670 | ||
| 0.089 | 0.014 | 0.089 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.102 | 0.029 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_154699670 | CID_154699670 | |
| 0.087 | 0.014 | 0.087 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.088 | 0.016 | 0.088 | Heat shock protein 90 beta antagonist | |||
| 0.09 | 0.018 | 0.09 | GABA receptor antagonist | |||
| 0.118 | 0.045 | 0.118 | Adenylate kinase inhibitor | 0.09 0.088 CID_154699670 | ||
| 0.077 | 0.005 | 0.087 | Neuraminidase (Influenza A) inhibitor | 0.087 0.004 CID_154699670 | CID_154699670 | |
| 0.098 | 0.027 | 0.098 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.129 | 0.058 | 0.152 | Beta amyloid protein antagonist | 0.152 0.039 CID_154699670 | CID_154699670 | |
| 0.117 | 0.047 | 0.117 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.091 | 0.022 | 0.169 | Carbonic anhydrase XII inhibitor | 0.169 0.01 CID_154699670 | CID_154699670 | |
| 0.086 | 0.018 | 0.086 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.109 | 0.042 | 0.109 | NMDA receptor antagonist | |||
| 0.097 | 0.033 | 0.19 | Phosphofructokinase-1 inhibitor | 0.19 0.012 CID_154699670 | CID_154699670 | |
| 0.146 | 0.081 | 0.311 | Diuretic | 0.311 0.021 CID_154699670 | CID_154699670 | |
| 0.086 | 0.022 | 0.086 | Purinergic P2X1 antagonist | |||
| 0.076 | 0.013 | 0.076 | Dihydroorotate oxidase inhibitor | |||
| 0.122 | 0.059 | 0.158 | Microtubule formation inhibitor | 0.158 0.034 CID_154699670 | CID_154699670 | |
| 0.094 | 0.032 | 0.122 | T cell inhibitor | 0.122 0.014 CID_154699670 | CID_154699670 | |
| 0.124 | 0.064 | 0.124 | Adenylate cyclase inhibitor | |||
| 0.071 | 0.012 | 0.071 | CXC chemokine 1 receptor antagonist | |||
| 0.082 | 0.022 | 0.082 | Glutamate (mGluR6) antagonist | |||
| 0.073 | 0.014 | 0.073 | Ryanodine receptor antagonist | |||
| 0.089 | 0.03 | 0.089 | MAP3K7 inhibitor | |||
| 0.076 | 0.019 | 0.076 | Sphingosine kinase inhibitor | |||
| 0.082 | 0.025 | 0.082 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.064 | 0.007 | 0.064 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.103 | 0.047 | 0.147 | Phosphodiesterase 6D inhibitor | 0.147 0.01 CID_154699670 | CID_154699670 | |
| 0.07 | 0.014 | 0.07 | Leukotriene C antagonist | |||
| 0.073 | 0.018 | 0.121 | Leukotriene B4 antagonist | 0.121 0.007 CID_154699670 | CID_154699670 | |
| 0.175 | 0.12 | 0.175 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.079 | 0.024 | 0.079 | Androgen agonist | |||
| 0.096 | 0.041 | 0.096 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.088 | 0.034 | 0.088 | CDK1/cyclin B1 inhibitor | |||
| 0.153 | 0.099 | 0.153 | Death-associated protein kinase 2 inhibitor | |||
| 0.158 | 0.105 | 0.158 | Anesthetic general | 0.148 0.116 CID_154699670 | ||
| 0.089 | 0.038 | 0.089 | Ca(v)3.1 blocker | |||
| 0.067 | 0.017 | 0.067 | Potassium channel Kv1.3 blocker | |||
| 0.076 | 0.027 | 0.076 | Beta 3 adrenoreceptor antagonist | |||
| 0.081 | 0.032 | 0.081 | Dopamine D1 antagonist | |||
| 0.107 | 0.059 | 0.178 | Toll-Like receptor 4 antagonist | 0.178 0.01 CID_154699670 | CID_154699670 | |
| 0.092 | 0.044 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.099 | 0.051 | 0.099 | Bile acid receptor antagonist | |||
| 0.099 | 0.052 | 0.099 | ABCA1 expression enhancer | |||
| 0.086 | 0.04 | 0.086 | Glutamate dehydrogenase inhibitor | |||
| 0.06 | 0.014 | 0.06 | Purinergic P2X4 antagonist | |||
| 0.057 | 0.012 | 0.057 | DNA gyrase subunit A inhibitor | 0.041 0.033 CID_154699670 | ||
| 0.086 | 0.043 | 0.086 | Phosphodiesterase 4D inhibitor | |||
| 0.071 | 0.029 | 0.071 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.082 | 0.041 | 0.082 | Adenosine A3 receptor antagonist | |||
| 0.108 | 0.067 | 0.108 | 5 Hydroxytryptamine 3A agonist | |||
| 0.08 | 0.039 | 0.08 | Glycine receptor agonist | 0.073 0.05 CID_154699670 | ||
| 0.089 | 0.048 | 0.089 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.059 | 0.019 | 0.059 | Adenylate cyclase 1 inhibitor | |||
| 0.122 | 0.082 | 0.122 | Vanilloid 1 agonist | 0.114 0.104 CID_154699670 | ||
| 0.103 | 0.064 | 0.103 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.058 | 0.02 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_154699670 | CID_154699670 | |
| 0.097 | 0.06 | 0.097 | MAP kinase kinase 1 inhibitor | |||
| 0.046 | 0.008 | 0.046 | Dopamine autoreceptor agonist | |||
| 0.079 | 0.042 | 0.085 | Phosphodiesterase VI inhibitor | 0.085 0.033 CID_154699670 | CID_154699670 | |
| 0.05 | 0.014 | 0.05 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.061 | 0.025 | 0.061 | Aconitate hydratase inhibitor | |||
| 0.066 | 0.031 | 0.066 | Protein kinase C eta inhibitor | |||
| 0.079 | 0.045 | 0.079 | GABA B receptor agonist | |||
| 0.07 | 0.036 | 0.07 | NMDA receptor glycine site agonist | |||
| 0.062 | 0.029 | 0.062 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.044 | 0.011 | 0.044 | Catechol O-methyltransferase inhibitor | |||
| 0.056 | 0.024 | 0.056 | Squalene epoxidase inhibitor | |||
| 0.098 | 0.066 | 0.098 | Aminopeptidase B inhibitor | |||
| 0.079 | 0.048 | 0.079 | GABA aminotransferase inhibitor | 0.073 0.057 CID_154699670 | ||
| 0.046 | 0.014 | 0.046 | Leukotriene C4 antagonist | |||
| 0.063 | 0.032 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.065 0.03 CID_154699670 | CID_154699670 | |
| 0.092 | 0.062 | 0.116 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.116 0.041 CID_154699670 | CID_154699670 | |
| 0.057 | 0.027 | 0.113 | Glucose-6-phosphate translocase inhibitor | 0.113 0.005 CID_154699670 | CID_154699670 | |
| 0.119 | 0.091 | 0.119 | Cytokine production inhibitor | |||
| 0.059 | 0.031 | 0.059 | GABA A receptor antagonist | |||
| 0.054 | 0.026 | 0.054 | Adenosine deaminase inhibitor | 0.047 0.033 CID_154699670 | ||
| 0.129 | 0.102 | 0.129 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.046 | 0.018 | 0.046 | Retinoic acid alpha receptor agonist | |||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | |||
| 0.063 | 0.037 | 0.063 | Heme oxygenase stimulant | |||
| 0.051 | 0.024 | 0.051 | Carbonic anhydrase IV inhibitor | |||
| 0.035 | 0.009 | 0.035 | Estrone sulfatase inhibitor | |||
| 0.064 | 0.039 | 0.064 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.119 | 0.096 | 0.119 | Neurotrophic factor | 0.115 0.104 CID_154699670 | ||
| 0.274 | 0.25 | 0.274 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.045 | 0.022 | 0.045 | Heme oxygenase inhibitor | |||
| 0.07 | 0.048 | 0.07 | Protein kinase C beta inhibitor | |||
| 0.154 | 0.133 | 0.154 | Growth factor agonist | |||
| 0.043 | 0.023 | 0.043 | NMDA receptor subunit 3A antagonist | |||
| 0.058 | 0.038 | 0.058 | Argininosuccinate synthase inhibitor | |||
| 0.195 | 0.175 | 0.35 | Angiogenesis inhibitor | 0.35 0.071 CID_154699670 | CID_154699670 | |
| 0.063 | 0.044 | 0.064 | Carbonic anhydrase inhibitor | 0.064 0.044 CID_154699670 | CID_154699670 | |
| 0.053 | 0.035 | 0.053 | NMDA 2A receptor antagonist | |||
| 0.037 | 0.019 | 0.037 | Estrogen-related receptor alpha antagonist | |||
| 0.039 | 0.022 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.04 | 0.023 | 0.04 | Glutamate (mGluR8) agonist | |||
| 0.069 | 0.052 | 0.069 | Secretase beta inhibitor | |||
| 0.043 | 0.027 | 0.043 | Cathepsin L2 inhibitor | |||
| 0.094 | 0.078 | 0.094 | Ferrochelatase inhibitor | |||
| 0.04 | 0.024 | 0.04 | Retinoid X receptor antagonist | |||
| 0.075 | 0.06 | 0.096 | Interferon agonist | 0.096 0.032 CID_154699670 | CID_154699670 | |
| 0.089 | 0.074 | 0.089 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.061 | 0.046 | 0.088 | Nitric oxide donor | 0.088 0.015 CID_154699670 | CID_154699670 | |
| 0.13 | 0.115 | 0.13 | MAP kinase kinase 4 inhibitor | |||
| 0.118 | 0.103 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.222 | 0.208 | 0.222 | Transcription factor inhibitor | |||
| 0.028 | 0.015 | 0.115 | Sodium/glucose cotransporter 2 inhibitor | 0.115 0.002 CID_154699670 | CID_154699670 | |
| 0.122 | 0.108 | 0.362 | Thrombolytic | 0.362 0.015 CID_154699670 | CID_154699670 | |
| 0.022 | 0.008 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_154699670 | CID_154699670 | |
| 0.072 | 0.059 | 0.072 | Vanilloid 4 agonist | |||
| 0.058 | 0.046 | 0.058 | TRPA1 antagonist | |||
| 0.114 | 0.102 | 0.114 | CDC-like kinase 1 inhibitor | |||
| 0.068 | 0.056 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.078 | 0.067 | 0.078 | Caspase 7 inhibitor | |||
| 0.024 | 0.013 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 CID_154699670 | CID_154699670 | |
| 0.055 | 0.045 | 0.055 | Pregnane X receptor antagonist | |||
| 0.017 | 0.007 | 0.017 | Antibiotic Tetracycline-like | |||
| 0.099 | 0.09 | 0.099 | Acetylcholine release stimulant | 0.099 0.089 CID_154699670 | ||
| 0.026 | 0.017 | 0.102 | Sodium/glucose cotransporter inhibitor | 0.102 0.003 CID_154699670 | CID_154699670 | |
| 0.032 | 0.024 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.053 | 0.045 | 0.053 | Adenosine A1 receptor antagonist | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.02 | 0.013 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thyroid hormone agonist | |||
| 0.048 | 0.041 | 0.048 | mTOR inhibitor | |||
| 0.025 | 0.018 | 0.042 | Vanilloid 2 agonist | 0.042 0.004 CID_154699670 | CID_154699670 | |
| 0.04 | 0.034 | 0.04 | NMDA receptor subunit 3B antagonist | |||
| 0.086 | 0.08 | 0.086 | Alpha 2c adrenoreceptor antagonist | |||
| 0.026 | 0.021 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_154699670 | ||
| 0.057 | 0.052 | 0.057 | NMDA receptor agonist | |||
| 0.059 | 0.053 | 0.059 | Dopamine agonist | |||
| 0.056 | 0.051 | 0.056 | NMDA 2C receptor antagonist | |||
| 0.027 | 0.023 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.023 | 0.02 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.038 | 0.035 | 0.038 | Sphingosine kinase 1 inhibitor | |||
| 0.073 | 0.07 | 0.117 | Glycine receptor antagonist | 0.117 0.02 CID_154699670 | CID_154699670 | |
| 0.031 | 0.028 | 0.031 | Progesterone antagonist | |||
| 0.099 | 0.096 | 0.099 | MAP kinase kinase inhibitor | |||
| 0.021 | 0.019 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.038 | 0.036 | 0.038 | Leukocyte elastase inhibitor | |||
| 0.049 | 0.048 | 0.157 | Heparanase inhibitor | 0.157 0.003 CID_154699670 | CID_154699670 | |
| 0.044 | 0.043 | 0.044 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.159 | 0.159 | 0.297 | Interleukin agonist | 0.297 0.05 CID_154699670 | CID_154699670 | |
| 0.021 | 0.021 | 0.077 | Protein 30S ribosomal subunit inhibitor | 0.077 0.004 CID_154699670 | CID_154699670 | |
| 0.015 | 0.017 | 0.022 | Telomerase stimulant | 0.022 0.006 CID_154699670 | CID_154699670 | |
| 0.057 | 0.063 | 0.071 | Interferon inducer | 0.071 0.034 CID_154699670 | CID_154699670 | |
| 0.043 | 0.051 | 0.054 | Cytokine production stimulant | 0.054 0.02 CID_154699670 | CID_154699670 | |
| 0.16 | 0.169 | 0.401 | Peptidyltransferase inhibitor | 0.401 0.007 CID_154699670 | CID_154699670 | |
| 0.038 | 0.053 | 0.059 | Carbonic anhydrase IX inhibitor | 0.059 0.037 CID_154699670 | CID_154699670 | |
| 0.007 | 0.023 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_154699670 | CID_154699670 | |
| 0.016 | 0.035 | 0.029 | Dopamine D1 agonist | 0.029 0.01 CID_154699670 | CID_154699670 | |
| 0.04 | 0.07 | 0.081 | Alpha-mannosidase inhibitor | 0.081 0.011 CID_154699670 | CID_154699670 | |
| 0.026 | 0.06 | 0.084 | Antibiotic Aminoglycoside-like | 0.084 0.004 CID_154699670 | CID_154699670 | |
| 0.027 | 0.075 | 0.075 | Mannosidase inhibitor | 0.075 0.01 CID_154699670 | CID_154699670 | |
| 0.126 | 0.176 | 0.36 | Platelet antagonist | 0.36 0.036 CID_154699670 | CID_154699670 | |
| 0.041 | 0.1 | 0.059 | Transcription factor AP-1 inhibitor | 0.059 0.047 CID_154699670 | CID_154699670 | |
| 0.005 | 0.064 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_154699670 | CID_154699670 | |
| 0.021 | 0.09 | 0.072 | Phosphorylase inhibitor | 0.072 0.019 CID_154699670 | CID_154699670 | |
| 0.015 | 0.089 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 CID_154699670 | CID_154699670 | |
| 0.043 | 0.124 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_154699670 | CID_154699670 | |
| 0.109 | 0.192 | 0.151 | CC chemokine 6 receptor antagonist | 0.151 0.02 CID_154699670 | CID_154699670 | |
| 0.035 | 0.118 | 0.052 | Factor III inhibitor | 0.052 0.029 CID_154699670 | CID_154699670 | |
| 0.027 | 0.119 | 0.386 | Selectin antagonist | 0.386 0.003 CID_154699670 | CID_154699670 | |
| 0.051 | 0.15 | 0.104 | Falcipain 2 inhibitor | 0.104 0.05 CID_154699670 | CID_154699670 | |
| 0.053 | 0.154 | 0.106 | Falcipain inhibitor | 0.106 0.051 CID_154699670 | CID_154699670 | |
| 0.038 | 0.143 | 0.067 | Adenine nucleotide translocase inhibitor | 0.067 0.018 CID_154699670 | CID_154699670 | |
| 0.023 | 0.134 | 0.048 | Microtubule stabilization | 0.048 0.03 CID_154699670 | CID_154699670 | |
| 0.099 | 0.212 | 0.31 | Hypolipemic | 0.31 0.046 CID_154699670 | CID_154699670 | |
| 0.002 | 0.125 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 CID_154699670 | CID_154699670 | |
| 0.055 | 0.181 | 0.148 | Transcription factor NF kappa B stimulant | 0.148 0.016 CID_154699670 | CID_154699670 | |
| 0.152 | 0.292 | 0.419 | Interleukin 2 agonist | 0.419 0.022 CID_154699670 | CID_154699670 | |
| 0.019 | 0.176 | 0.111 | Protein 50S ribosomal subunit inhibitor | 0.111 0.011 CID_154699670 | CID_154699670 | |
| 0.027 | 0.205 | 0.066 | DNA gyrase inhibitor | 0.066 0.041 CID_154699670 | CID_154699670 | |
| 0.037 | 0.24 | 0.122 | ATPase (Vacuolar H+) inhibitor | 0.122 0.018 CID_154699670 | CID_154699670 | |
| 0.036 | 0.407 | 0.258 | Cell adhesion inhibitor | 0.258 0.014 CID_154699670 | CID_154699670 | |
| 0.063 | 0.512 | 0.435 | Immunomodulator | 0.435 0.035 CID_154699670 | CID_154699670 | |
| 0.01 | 0.533 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.011 CID_154699670 | CID_154699670 | |
| 0.013 | 0.553 | 0.113 | Cell adhesion molecule inhibitor | 0.113 0.027 CID_154699670 | CID_154699670 | |
| 0.012 | 0.657 | 0.207 | Anticoagulant | 0.207 0.05 CID_154699670 | CID_154699670 | |
| 0.013 | 0.687 | 0.075 | Factor IXa inhibitor | 0.075 0.018 CID_154699670 | CID_154699670 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |